Generation of bioluminescent enzyme immunoassay for ferritin by single-chain variable fragment and its NanoLuc luciferase fusion
- PMID: 35945290
- PMCID: PMC9531656
- DOI: 10.1007/s00216-022-04261-7
Generation of bioluminescent enzyme immunoassay for ferritin by single-chain variable fragment and its NanoLuc luciferase fusion
Abstract
Ferritin, widely present in liver and spleen tissue, is considered as a serological biomarker for liver diseases and cancers. The detection of ferritin may be an important tool in health diagnosis. In this study, 14 non-immunized chicken spleens were utilized to construct a single-chain fragment (scFv) phage library. After 4 rounds of panning, 7 unique clones were obtained. The optimal clone was further screened and combined with NanoLuc luciferase (Nluc) as a dual functional immunoprobe to bioluminescent enzyme immunoassay (BLEIA), which was twice as sensitive as its parental scFv-based double-sandwich enzyme-linked immunoassay (ds-ELISA). The cross-reactivity analysis revealed that the proposed methods were highly selective and suitable for clinical detection. To further verify the performance of the immunoassays, serum samples were tested by the proposed methods and a commercial ELISA kit, and there was a good correlation between the results. These results suggested that scFv fused with Nluc might be a powerful dual functional tool for rapid, practically reliable, and highly sensitive ferritin detection.
Keywords: Bioluminescent enzyme immunoassay; Biomarker; Ferritin; NanoLuc luciferase; Single-chain variable fragment.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Conflict of interest
The authors declare that there is no conflict of interests to publish this paper.
Figures




Similar articles
-
NanoLuc luciferase as a suitable fusion partner of recombinant antibody fragments for developing sensitive luminescent immunoassays.Anal Chim Acta. 2021 May 29;1161:238180. doi: 10.1016/j.aca.2020.12.055. Epub 2021 Jan 6. Anal Chim Acta. 2021. PMID: 33896564
-
Rapid and sensitive detection of SARS-CoV-2 based on a phage-displayed scFv antibody fusion with alkaline phosphatase and NanoLuc luciferase.Anal Chim Acta. 2024 Sep 15;1322:343057. doi: 10.1016/j.aca.2024.343057. Epub 2024 Aug 3. Anal Chim Acta. 2024. PMID: 39182992
-
Chemiluminescent Enzyme Immunoassay and Bioluminescent Enzyme Immunoassay for Tenuazonic Acid Mycotoxin by Exploitation of Nanobody and Nanobody-Nanoluciferase Fusion.Anal Chem. 2020 Sep 1;92(17):11935-11942. doi: 10.1021/acs.analchem.0c02338. Epub 2020 Aug 11. Anal Chem. 2020. PMID: 32702970 Free PMC article.
-
Production and characterization of a biotinylated single-chain variable fragment antibody for detection of parathion-methyl.Protein Expr Purif. 2016 Oct;126:1-8. doi: 10.1016/j.pep.2016.05.005. Epub 2016 May 12. Protein Expr Purif. 2016. PMID: 27181246 Review.
-
Luciola mingrelica firefly luciferase as a marker in bioluminescent immunoassays.Biophys Rev. 2023 Aug 18;15(5):955-962. doi: 10.1007/s12551-023-01115-z. eCollection 2023 Oct. Biophys Rev. 2023. PMID: 37975007 Free PMC article. Review.
Cited by
-
Development of alkaline phosphatase-linked single-chain variable fragment fusion proteins for one-step immunodetection of deoxynivalenol in cereals.Anal Bioanal Chem. 2024 May;416(12):2929-2939. doi: 10.1007/s00216-024-05241-9. Epub 2024 Mar 16. Anal Bioanal Chem. 2024. PMID: 38491149
-
Mix-and-Read Nanobody-Based Sandwich Homogeneous Split-Luciferase Assay for the Rapid Detection of Human Soluble Epoxide Hydrolase.Anal Chem. 2023 Apr 11;95(14):6038-6045. doi: 10.1021/acs.analchem.3c00079. Epub 2023 Mar 27. Anal Chem. 2023. PMID: 36972550 Free PMC article.
References
-
- Pauline M Harrison PA (1996) The ferritins” molecular properties, iron storage function and cellular regulation Biochimica et Biophysica Acta 1275:161–203 - PubMed
-
- Vohra I, Attar B, Katiyar V, Palacios P, Randhawa T, Baig MA, Flores E, Wang Y, Mutneja H, Sharma S, Lingamneni P, Farooq MZ, Bhaskaran N, Gandhi S, Vettiankal G, Demetria M (2021) Evaluation of Ferritin and Transferrin Ratio as a Prognostic Marker for Hepatocellular Carcinoma. J Gastrointest Cancer 52 (1):201–206. doi:10.1007/s12029-020-00373-4 - DOI - PubMed
MeSH terms
Substances
Grants and funding
- 201903010034/Guangzhou Science and Technology Foundation
- 2018A030313926/Natural Resources Science Foundation of Guangdong Province
- 2019B020209009/Science and Technology Foundation Key R&D Program of Guangdong Province
- R35 ES030443/ES/NIEHS NIH HHS/United States
- P42 ES004699/ES/NIEHS NIH HHS/United States